IBN
ICICI Bank Limited
IBN offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
JPM
JPMorgan Chase & Co.
JPM has a slight edge over IBN overall, supported by stronger modeled upside and stronger fundamentals.
IBN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| N/A | |
| N/A |
IBN's profitability is currently strong, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like IBN.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
IBN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 18x | $30.21 | -12% |
| Fair | 19x | $32.33 | -6% |
| Expensive | 21x | $34.73 | +1% |
| Current | 21x | $34.39 | — |
Historical ranges are pointers, not guarantees.
IBN has the edge over JPM in the historical PE scenario, which offers more potential upside but is not a forecast.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
IBN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Strong growth | |
| Strongly weakening | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for IBN, but weaker profitability.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
JPM has the edge over IBN on the outlook, with more favorable profitability expectations.
IBN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $1.66 | +5.7% |
| Q1 2026 | $1.60 | +5.3% |
| Q4 2025 | $1.57 | +7.5% |
| Q3 2025 | $1.58 | +12% |
| Q2 2025 | $1.57 | +16% |
| Q1 2025 | $1.52 | +15% |
| Q4 2024 | $1.46 | +15% |
| Q3 2024 | $1.41 | +18% |
IBN's earnings per share have climbed steadily: $1.66 over the past year, up 5.7% from the year before, and higher year over year for 15 quarters in a row.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over IBN on earnings, with stronger typical year-over-year growth.
IBN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $6.6B | -18% |
| Q1 2026 | $9B | +6.1% |
| Q4 2025 | $8.3B | +3.8% |
| Q3 2025 | $8.1B | +4.4% |
| Q2 2025 | $8B | +11% |
| Q1 2025 | $8.5B | +20% |
| Q4 2024 | $8B | +25% |
| Q3 2024 | $7.8B | +27% |
IBN's revenue has held roughly level: $6.6B last quarter, down 18% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 35% | +8.6 points |
| Q1 2026 | 25% | +0.8 points |
| Q4 2025 | 23% | -1.6 points |
| Q3 2025 | 25% | -0.4 points |
| Q2 2025 | 26% | +1.2 points |
| Q1 2025 | 24% | -0.8 points |
| Q4 2024 | 25% | -1.1 points |
| Q3 2024 | 25% | -1 points |
IBN's operating margin was 35% last quarter, up 8.6 points from the same quarter a year ago, near the top of its range since 2019.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over IBN on profitability, with a higher operating margin.
IBN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | $0 |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | $0 |
| Q3 2025 | $0 | $0 |
| Q2 2025 | $0 | $0 |
| Q1 2025 | $0 | $0 |
| Q4 2024 | $0 | $0 |
| Q3 2024 | $0 | $0 |
IBN's free cash flow was $0 over the past year, against $0 the year before. Free cash flow isn't a meaningful measure for financial services companies like IBN.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM has the edge over IBN on cash flow, with more consistent year-over-year improvement.
IBN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.1% | +2.6M shares |
| 1 year | +0.1% | +3M shares |
| 3 years | +1.7% | +59.4M shares |
| 5 years | +2.6% | +92.9M shares |
| Available history | +7.5% | +254M shares |
IBN has 3.6B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
IBN hasn't bought back shares in the past year.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over IBN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
IBN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.4x | Very low |
| Q1 2026 | -0.6x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | -0.4x | Net Cash |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | 0.8x | Very low |
IBN has the edge over JPM on leverage, with a lower net debt burden relative to earnings.
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
IBN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 71.0 | Overbought |
| Stochastic | 85.3 | Overbought |
IBN's weekly RSI is 71 (overbought) and its Stochastic is 85 (overbought).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
IBN PE vs Financial Services Sector
| Metric | IBN | Sector median | Relative |
|---|---|---|---|
| PE | 21x | 13x | 60% above |
| PE % | 79 | 63 | 16 pts above |
IBN is trading at 21x earnings, a 60% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM has the edge over IBN on valuation relative to its sector.
IBN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $30.1 | 14% above |
| 20 week MA | $29.8 | 15% above |
| 50 week MA | $29.0 | 19% above |
| 100 week MA | $30.2 | 14% above |
| 200 week MA | $27.7 | 24% above |
IBN has the edge over JPM on trend strength, trading above more of its moving averages.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM's trend is mixed: it's above four of its five weekly moving averages, and 45% above its 200-week average.
IBN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $15.3 | $14.0 | -8.4% |
| 2021 | $14.0 | $19.3 | +38% |
| 2022 | $19.3 | $21.6 | +12% |
| 2023 | $21.6 | $23.8 | +11% |
| 2024 | $23.8 | $30.5 | +28% |
| 2025 | $30.5 | $30.1 | -1.3% |
| 2026 YTD | $30.1 | $34.4 | +14% |
IBN has the edge over JPM on returns for 2026, with the stronger performance.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has finished higher in four of the last six years. It's up 4.5% so far in 2026.